Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP180068.RAYRNfODaL3gXi8VlglSYGQ5LgWZYi-EnH1bk80UVWnDY130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180068.RAYRNfODaL3gXi8VlglSYGQ5LgWZYi-EnH1bk80UVWnDY130_provenance.
• NP382245.RABvGiQPl24JOwym46lQdVUEIx_OCJj-wkfMmzbwbMKKY130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382245.RABvGiQPl24JOwym46lQdVUEIx_OCJj-wkfMmzbwbMKKY130_provenance.
• NP469069.RAbdnlXRNie0haSiXWq4DSYmSZ9Ewgjlc_dJCne4nhTe0130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469069.RAbdnlXRNie0haSiXWq4DSYmSZ9Ewgjlc_dJCne4nhTe0130_provenance.
• assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP233261.RAwWRuoYcole7G0Xu6rySYIGfXTIK5EQxudIo9YqgTUJM130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233261.RAwWRuoYcole7G0Xu6rySYIGfXTIK5EQxudIo9YqgTUJM130_provenance.
• assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP775316.RA5Cq88EW0qhEnzEESl30cO_LthSEP1UXaZT4SdyHSMD8130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775316.RA5Cq88EW0qhEnzEESl30cO_LthSEP1UXaZT4SdyHSMD8130_provenance.
• NP772787.RAAKo3k8mxr8WRc89ygkGtDE7_JWIb4VzMnssURGr_fh0130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772787.RAAKo3k8mxr8WRc89ygkGtDE7_JWIb4VzMnssURGr_fh0130_provenance.
• NP772793.RAUHNaHQICSisY88YfefhhyvnHX1jGR2_zTStyDi0e6ww130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772793.RAUHNaHQICSisY88YfefhhyvnHX1jGR2_zTStyDi0e6ww130_provenance.
• NP772790.RAiU2p7UsqL-AHsDOXi12IPpatetZ0Ig5rvKDsjlqx7wE130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772790.RAiU2p7UsqL-AHsDOXi12IPpatetZ0Ig5rvKDsjlqx7wE130_provenance.
• NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772791.RAhenWlyQzj_Cz6pzTjb82k5ojG5InNREhfH9Ysx4BqR8130_provenance.
• NP772792.RAnlHmFU__nDEKalG7PKvLjfscO5sNbsN6X0FrGer40Ww130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772792.RAnlHmFU__nDEKalG7PKvLjfscO5sNbsN6X0FrGer40Ww130_provenance.
• NP772794.RAJze4WaevS8FIbTD3p1tTWKLrU4oylyLEXRCH3NOqi6E130_assertion description "[Presence of BRCA1/2 genes mutations in young women is associated with more aggressiveness of the breast cancer (their 3-years survival is 25,5% less) and absence of the ER, PR, HER-2 receptors, which is unfavorable prognostic factor in terms of hormone therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772794.RAJze4WaevS8FIbTD3p1tTWKLrU4oylyLEXRCH3NOqi6E130_provenance.